{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:08:17Z","timestamp":1794344897497,"version":"4.9.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"DOI":"10.1038\/s41533-025-00477-z","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:25:42Z","timestamp":1767828342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A deep dive into atrial fibrillation in chronic obstructive pulmonary disease"],"prefix":"10.1038","volume":"36","author":[{"given":"Yusuf Ziya","family":"Sener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr","family":"Ceasovschih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkeaiym","family":"Murzalieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Oksul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan Gokalp","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Faruk","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Belancic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Allamsetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Piotrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Corlateanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victorita","family":"Sorodoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"477_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccm.2020.05.002","volume":"41","author":"L Ruvuna","year":"2020","unstructured":"Ruvuna, L. & Sood, A. Epidemiology of chronic obstructive pulmonary disease. Clin. Chest Med. 41, 315\u2013327 (2020).","journal-title":"Clin. Chest Med."},{"key":"477_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/resp.14489","volume":"28","author":"PMA Calverley","year":"2023","unstructured":"Calverley, P. M. A. & Walker, P. P. Contemporary concise review 2022: chronic obstructive pulmonary disease. Respirology 28, 428\u2013436 (2023).","journal-title":"Respirology"},{"key":"477_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392, 2052\u20132090 (2018).","journal-title":"Lancet"},{"key":"477_CR4","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/life13061299","volume":"13","author":"A Papaporfyriou","year":"2023","unstructured":"Papaporfyriou, A. et al. Cardiovascular diseases in COPD: from diagnosis and prevalence to therapy. Life 13, 1299 (2023).","journal-title":"Life"},{"key":"477_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","volume":"3","author":"W Chen","year":"2015","unstructured":"Chen, W., Thomas, J., Sadatsafavi, M. & FitzGerald, J. M. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir. Med. 3, 631\u2013639 (2015).","journal-title":"Lancet Respir. Med."},{"key":"477_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.amjcard.2014.04.030","volume":"114","author":"T Konecny","year":"2014","unstructured":"Konecny, T. et al. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am. J. Cardiol. 114, 272\u2013277 (2014).","journal-title":"Am. J. Cardiol."},{"key":"477_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/eurheartj\/ehaa822","volume":"42","author":"SO Simons","year":"2021","unstructured":"Simons, S. O. et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur. Heart J. 42, 532\u2013540 (2021).","journal-title":"Eur. Heart J."},{"key":"477_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40256-024-00703-y","volume":"25","author":"A Zobdeh","year":"2025","unstructured":"Zobdeh, A., Hoyle, D. J., Shastri, P., Bezabhe, W. M. & Peterson, G. M. Prevention of new-onset heart failure in atrial fibrillation: the role of pharmacological management. Am. J. Cardiovasc. Drugs 25, 147\u2013155 (2025).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"477_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100786","volume":"37","author":"D Linz","year":"2024","unstructured":"Linz, D. et al. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg. Health Eur. 37, 100786 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"477_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106519","volume":"185","author":"A Corlateanu","year":"2021","unstructured":"Corlateanu, A. et al. Multidimensional indices in the assessment of chronic obstructive pulmonary disease. Respir. Med. 185, 106519 (2021).","journal-title":"Respir. Med."},{"key":"477_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","volume":"83","author":"JA Joglar","year":"2024","unstructured":"Joglar, J. A. et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American heart association joint committee on clinical practice guidelines. J. Am. Coll. Cardiol. 83, 109\u2013279 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"477_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/clockssleep5020025","volume":"5","author":"V Sircu","year":"2023","unstructured":"Sircu, V. et al. The burden of comorbidities in obstructive sleep apnea and the pathophysiologic mechanisms and effects of CPAP. Clocks Sleep. 5, 333\u2013349 (2023).","journal-title":"Clocks Sleep."},{"key":"477_CR13","first-page":"11","volume":"15","author":"T Erg\u00fcl","year":"2025","unstructured":"Erg\u00fcl, T. et al. Prognostic accuracy of DECAF and ottawa COPD risk scores in patients presenting to the emergency department with COPD exacerbation. J. Acute Med. 15, 11\u201318 (2025).","journal-title":"J. Acute Med."},{"key":"477_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/medicina60030352","volume":"60","author":"S Kotlyarov","year":"2024","unstructured":"Kotlyarov, S. & Lyubavin, A. Early detection of atrial fibrillation in chronic obstructive pulmonary disease patients. Medicina 60, 352 (2024).","journal-title":"Medicina"},{"key":"477_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/ehjqcco\/qcac059","volume":"9","author":"PE Warming","year":"2023","unstructured":"Warming, P. E. et al. Atrial fibrillation and chronic obstructive pulmonary disease: diagnostic sequence and mortality risk. Eur. Heart J. Qual. Care Clin. Outcomes 9, 128\u2013134 (2023).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"477_CR16","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.2147\/COPD.S488701","volume":"20","author":"CF Vogelmeier","year":"2025","unstructured":"Vogelmeier, C. F. et al. Comorbidities and cause of death in COPD patients compared to Non-COPD controls: an 8-year observational retrospective healthcare claims database cohort study. Int. J. Chron. Obstruct Pulmon Dis. 20, 2117\u20132130 (2025).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"477_CR17","first-page":"e650","volume":"22","author":"HN Pham","year":"2025","unstructured":"Pham, H. N. et al. Incidence of arrhythmias in chronic obstructive pulmonary disease, obstructive sleep apnea, and overlap syndrome: A retrospective cohort study. Heart Rhythm. 22, e650\u2013e657 (2025).","journal-title":"Heart Rhythm."},{"key":"477_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijcard.2017.02.017","volume":"236","author":"M M\u00e9ndez-Bail\u00f3n","year":"2017","unstructured":"M\u00e9ndez-Bail\u00f3n, M. et al. Chronic obstructive pulmonary disease predicts higher incidence and in hospital mortality for atrial fibrillation. an observational study using hospital discharge data in Spain (2004-2013). Int. J. Cardiol. 236, 209\u2013215 (2017).","journal-title":"Int. J. Cardiol."},{"key":"477_CR19","doi-asserted-by":"publisher","first-page":"00193","DOI":"10.1183\/23120541.00193-2020","volume":"6","author":"AG Mathioudakis","year":"2020","unstructured":"Mathioudakis, A. G. et al. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS task force study protocol. ERJ Open. Res. 6, 00193\u201302020 (2020).","journal-title":"ERJ Open. Res."},{"key":"477_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.chest.2019.01.027","volume":"155","author":"SY Shin","year":"2019","unstructured":"Shin, S. Y., Manuel, A. R. G. & Lip, G. Y. H. Atrial fibrillation and End-Stage COPD: a close association revisited. Chest 155, 888\u2013889 (2019).","journal-title":"Chest"},{"key":"477_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3892\/etm.2024.12459","volume":"27","author":"T Huang","year":"2024","unstructured":"Huang, T., Huang, X., Cui, X. & Dong, Q. Predictive nomogram models for atrial fibrillation in COPD patients: A comprehensive analysis of risk factors and prognosis. Exp. Ther. Med. 27, 171 (2024).","journal-title":"Exp. Ther. Med."},{"key":"477_CR22","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1164\/rccm.202408-1625RL","volume":"211","author":"DM MacDonald","year":"2025","unstructured":"MacDonald, D. M. et al. Continuous monitoring for atrial fibrillation in individuals at increased risk of acute exacerbations of COPD. Am. J. Respir. Crit. Care Med. 211, 868\u2013870 (2025).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1164\/rccm.202501-0229ED","volume":"211","author":"S Bartlett-Pestell","year":"2025","unstructured":"Bartlett-Pestell, S., Wong, T. & Wedzicha, J. A. Exacerbating the Problem: COPD and Atrial Fibrillation. Am. J. Respir. Crit. Care Med. 211, 695\u2013697 (2025).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR24","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/eurjpc\/zwaf086","volume":"32","author":"M Zysman","year":"2025","unstructured":"Zysman, M. et al. Risk of cardiovascular events according to the severity of an exacerbation of chronic obstructive pulmonary disease. Eur. J. Prev. Cardiol. 32, 1436\u20131444 (2025).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"477_CR25","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2147\/COPD.S473289","volume":"19","author":"HL Nguyen","year":"2024","unstructured":"Nguyen, H. L., Nguyen, T. D. & Phan, P. T. Prevalence and associated factors of paroxysmal atrial fibrillation and atrial arrhythmias during hospitalizations for exacerbation of COPD. Int. J. Chron. Obstruct Pulmon Dis. 19, 1989\u20132000 (2024).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"477_CR26","doi-asserted-by":"publisher","first-page":"204589402091068","DOI":"10.1177\/2045894020910685","volume":"10","author":"CA Vahdatpour","year":"2020","unstructured":"Vahdatpour, C. A., Luebbert, J. J. & Palevsky, H. I. Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension. Pulm. Circ. 10, 2045894020910685 (2020).","journal-title":"Pulm. Circ."},{"key":"477_CR27","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10376","volume":"8","author":"Q Huang","year":"2020","unstructured":"Huang, Q. et al. Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. PeerJ 8, e10376 (2020).","journal-title":"PeerJ"},{"key":"477_CR28","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.2147\/COPD.S166534","volume":"13","author":"CY Chen","year":"2018","unstructured":"Chen, C. Y. & Liao, K. M. The impact of atrial fibrillation in patients with COPD during hospitalization. Int. J. Chron. Obstruct Pulmon Dis. 13, 2105\u20132112 (2018).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"477_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijcard.2018.09.056","volume":"276","author":"M Grymonprez","year":"2019","unstructured":"Grymonprez, M. et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int. J. Cardiol. 276, 118\u2013124 (2019).","journal-title":"Int. J. Cardiol."},{"key":"477_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0970-2113.197116","volume":"34","author":"M Sarkar","year":"2017","unstructured":"Sarkar, M., Niranjan, N. & Banyal, P. K. Mechanisms of hypoxemia. Lung India 34, 47\u201360 (2017).","journal-title":"Lung India"},{"key":"477_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0022-0736(90)90152-R","volume":"23","author":"A Hirata","year":"1990","unstructured":"Hirata, A. Effect of hypoxia on electrical activity of atrioventricular nodal cells and atrial cells of the rabbit\u2019s heart. J. Electrocardiol. 23, 69\u201376 (1990).","journal-title":"J. Electrocardiol."},{"key":"477_CR32","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/01.RES.44.6.856","volume":"44","author":"J Senges","year":"1979","unstructured":"Senges, J. et al. Effect of hypoxia on the sinoatrial node, atrium, and atrioventricular node in the rabbit heart. Circ. Res. 44, 856\u2013863 (1979).","journal-title":"Circ. Res."},{"key":"477_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1042\/CS20110178","volume":"122","author":"YK Lin","year":"2012","unstructured":"Lin, Y. K. et al. Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium. Clin. Sci. 122, 121\u2013132 (2012).","journal-title":"Clin. Sci."},{"key":"477_CR34","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","volume":"63","author":"S Nattel","year":"2014","unstructured":"Nattel, S. & Harada, M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J. Am. Coll. Cardiol. 63, 2335\u20132345 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"477_CR35","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s11010-021-04082-9","volume":"476","author":"S Babapoor-Farrokhran","year":"2021","unstructured":"Babapoor-Farrokhran, S., Gill, D., Alzubi, J. & Mainigi, S. K. Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines. Mol. Cell Biochem. 476, 2283\u20132293 (2021).","journal-title":"Mol. Cell Biochem."},{"key":"477_CR36","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","volume":"138","author":"C Yao","year":"2018","unstructured":"Yao, C. et al. Enhanced Cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation 138, 2227\u20132242 (2018).","journal-title":"Circulation"},{"key":"477_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.carpath.2008.11.001","volume":"19","author":"F Gramley","year":"2010","unstructured":"Gramley, F. et al. Atrial fibrillation is associated with cardiac hypoxia. Cardiovasc. Pathol. 19, 102\u2013111 (2010).","journal-title":"Cardiovasc. Pathol."},{"key":"477_CR38","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1253\/circj.CJ-09-0969","volume":"74","author":"H Ogi","year":"2010","unstructured":"Ogi, H. et al. Is structural remodeling of fibrillated atria the consequence of tissue hypoxia? Circ. J. 74, 1815\u20131821 (2010).","journal-title":"Circ. J."},{"key":"477_CR39","first-page":"vi1","volume":"63","author":"BR O\u2019Driscoll","year":"2008","unstructured":"O\u2019Driscoll, B. R., Howard, L. S., Davison, A. G. & British Thoracic S. BTS guideline for emergency oxygen use in adult patients. Thorax 63, vi1\u2013vi68 (2008).","journal-title":"Thorax"},{"key":"477_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-17686-9","volume":"24","author":"N Al Wachami","year":"2024","unstructured":"Al Wachami, N. et al. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMC Public. Health 24, 297 (2024).","journal-title":"BMC Public. Health"},{"key":"477_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijcard.2015.06.096","volume":"199","author":"CA Goudis","year":"2015","unstructured":"Goudis, C. A., Konstantinidis, A. K., Ntalas, I. V. & Korantzopoulos, P. Electrocardiographic abnormalities and cardiac arrhythmias in chronic obstructive pulmonary disease. Int. J. Cardiol. 199, 264\u2013273 (2015).","journal-title":"Int. J. Cardiol."},{"key":"477_CR42","doi-asserted-by":"publisher","unstructured":"Sarkar M., Madabhavi I., Kadakol N. Oxygen-induced hypercapnia: physiological mechanisms and clinical implications. Monaldi Arch Chest Dis. 93 https:\/\/doi.org\/10.4081\/monaldi.2022.2399 2022.","DOI":"10.4081\/monaldi.2022.2399"},{"key":"477_CR43","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.hrthm.2010.03.020","volume":"7","author":"IH Stevenson","year":"2010","unstructured":"Stevenson, I. H. et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 7, 1263\u20131270 (2010).","journal-title":"Heart Rhythm."},{"key":"477_CR44","first-page":"2908","volume":"18","author":"C Terzano","year":"2014","unstructured":"Terzano, C. et al. Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur. Rev. Med. Pharmacol. Sci. 18, 2908\u20132917 (2014).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"477_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jamda.2014.04.009","volume":"15","author":"B Huang","year":"2014","unstructured":"Huang, B. et al. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study. J. Am. Med. Dir. Assoc. 15, 576\u2013581 (2014).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"477_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ahj.2016.08.011","volume":"181","author":"M Proietti","year":"2016","unstructured":"Proietti, M. et al. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational research programme pilot survey on atrial fibrillation (EORP-AF) General Registry. Am. Heart J. 181, 83\u201391 (2016).","journal-title":"Am. Heart J."},{"key":"477_CR47","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jjcc.2016.12.013","volume":"69","author":"CA Goudis","year":"2017","unstructured":"Goudis, C. A. Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship. J. Cardiol. 69, 699\u2013705 (2017).","journal-title":"J. Cardiol."},{"key":"477_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5455\/msm.2017.29.231-236","volume":"29","author":"N Naser","year":"2017","unstructured":"Naser, N. et al. The impact of risk factors and comorbidities on the incidence of atrial fibrillation. Mater. Sociomed. 29, 231\u2013236 (2017).","journal-title":"Mater. Sociomed."},{"key":"477_CR49","first-page":"390","volume":"81","author":"E Weitzenblum","year":"2013","unstructured":"Weitzenblum, E., Chaouat, A. & Kessler, R. Pulmonary hypertension in chronic obstructive pulmonary disease. Pneumonol. Alergol. Pol. 81, 390\u2013398 (2013).","journal-title":"Pneumonol. Alergol. Pol."},{"key":"477_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijcard.2013.12.009","volume":"171","author":"EM Kallergis","year":"2014","unstructured":"Kallergis, E. M., Goudis, C. A. & Vardas, P. E. Atrial fibrillation: a progressive atrial myopathy or a distinct disease? Int. J. Cardiol. 171, 126\u2013133 (2014).","journal-title":"Int. J. Cardiol."},{"key":"477_CR51","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","volume":"12","author":"YF Hu","year":"2015","unstructured":"Hu, Y. F., Chen, Y. J., Lin, Y. J. & Chen, S. A. Inflammation and the pathogenesis of atrial fibrillation. Nat. Rev. Cardiology 12, 230\u2013243 (2015).","journal-title":"Nat. Rev. Cardiology"},{"key":"477_CR52","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1161\/hc4901.101760","volume":"104","author":"MK Chung","year":"2001","unstructured":"Chung, M. K. et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104, 2886\u20132891 (2001).","journal-title":"Circulation"},{"key":"477_CR53","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/europace\/eut158","volume":"15","author":"T Hayashi","year":"2013","unstructured":"Hayashi, T. et al. Prevalence and electrophysiological characteristics of typical atrial flutter in patients with atrial fibrillation and chronic obstructive pulmonary disease. Europace 15, 1777\u20131783 (2013).","journal-title":"Europace"},{"key":"477_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s40675-018-0117-4","volume":"4","author":"F Roder","year":"2018","unstructured":"Roder, F. et al. Interactions of sleep apnea, the autonomic nervous system, and its impact on cardiac arrhythmias. Curr. Sleep. Med. Rep. 4, 160\u2013169 (2018).","journal-title":"Curr. Sleep. Med. Rep."},{"key":"477_CR55","first-page":"215","volume":"2","author":"AJ van Gestel","year":"2010","unstructured":"van Gestel, A. J. & Steier, J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD). J. Thorac. Dis. 2, 215\u2013222 (2010).","journal-title":"J. Thorac. Dis."},{"key":"477_CR56","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1183\/09031936.93.04101207","volume":"4","author":"AG Stewart","year":"1991","unstructured":"Stewart, A. G., Waterhouse, J. C. & Howard, P. Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur. Respir. J. 4, 1207\u20131214 (1991).","journal-title":"Eur. Respir. J."},{"key":"477_CR57","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.rmed.2004.06.003","volume":"99","author":"SK Chhabra","year":"2005","unstructured":"Chhabra, S. K. & De, S. Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir. Med. 99, 126\u2013133 (2005).","journal-title":"Respir. Med."},{"key":"477_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.12965\/jer.2244586.293","volume":"19","author":"T Promsrisuk","year":"2023","unstructured":"Promsrisuk, T. et al. Oxidative stress associated with impaired autonomic control and severity of lung function in chronic obstructive pulmonary disease patients. J. Exerc. Rehabil. 19, 75\u201384 (2023).","journal-title":"J. Exerc. Rehabil."},{"key":"477_CR59","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1183\/09059180.00008612","volume":"22","author":"A Cavaill\u00e8s","year":"2013","unstructured":"Cavaill\u00e8s, A. et al. Comorbidities of COPD. Eur. Respir. Rev. 22, 454\u2013475 (2013).","journal-title":"Eur. Respir. Rev."},{"key":"477_CR60","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.hrthm.2011.03.038","volume":"8","author":"AM Chamberlain","year":"2011","unstructured":"Chamberlain, A. M. et al. Smoking and incidence of atrial fibrillation: results from the atherosclerosis risk in communities (ARIC) study. Heart Rhythm. 8, 1160\u20131166 (2011).","journal-title":"Heart Rhythm."},{"key":"477_CR61","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/15412555.2014.949001","volume":"12","author":"TJ Cunningham","year":"2015","unstructured":"Cunningham, T. J., Ford, E. S., Rolle, I. V., Wheaton, A. G. & Croft, J. B. Associations of self-reported cigarette smoking with chronic obstructive pulmonary disease and co-morbid chronic conditions in the United States. Copd 12, 276\u2013286 (2015).","journal-title":"Copd"},{"key":"477_CR62","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.ahj.2008.08.003","volume":"156","author":"J Heeringa","year":"2008","unstructured":"Heeringa, J., Kors, J. A., Hofman, A., van Rooij, F. J. & Witteman, J. C. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am. Heart J. 156, 1163\u20131169 (2008).","journal-title":"Am. Heart J."},{"key":"477_CR63","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1177\/2047487318791272","volume":"25","author":"TM Seccia","year":"2018","unstructured":"Seccia, T. M. & Cal\u00f2, L. A. Smoking causes atrial fibrillation? further evidence on a debated issue. Eur. J. Prev. Cardiol. 25, 1434\u20131436 (2018).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"477_CR64","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1136\/heartjnl-2017-312735","volume":"104","author":"MT Durheim","year":"2018","unstructured":"Durheim, M. T. et al. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart 104, 1850\u20131858 (2018).","journal-title":"Heart"},{"key":"477_CR65","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/thx.2007.086827","volume":"63","author":"FM Franssen","year":"2008","unstructured":"Franssen, F. M., O\u2019Donnell, D. E., Goossens, G. H., Blaak, E. E. & Schols, A. M. Obesity and the lung: 5. obesity and COPD. Thorax 63, 1110\u20131117 (2008).","journal-title":"Thorax"},{"key":"477_CR66","doi-asserted-by":"publisher","first-page":"e105220","DOI":"10.1371\/journal.pone.0105220","volume":"9","author":"F Garc\u00eda-Rio","year":"2014","unstructured":"Garc\u00eda-Rio, F. et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One 9, e105220 (2014).","journal-title":"PLoS One"},{"key":"477_CR67","doi-asserted-by":"publisher","first-page":"e0147065","DOI":"10.1371\/journal.pone.0147065","volume":"11","author":"Y Kwon","year":"2016","unstructured":"Kwon, Y. et al. Association of smoking, alcohol, and obesity with cardiovascular death and ischemic stroke in atrial fibrillation: the atherosclerosis risk in communities (ARIC) study and cardiovascular health study (CHS). PLoS One 11, e0147065 (2016).","journal-title":"PLoS One"},{"key":"477_CR68","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/01.CIR.82.3.792","volume":"82","author":"AJ Sanfilippo","year":"1990","unstructured":"Sanfilippo, A. J. et al. Atrial enlargement as a consequence of atrial fibrillation. a prospective echocardiographic study. Circulation 82, 792\u2013797 (1990).","journal-title":"Circulation"},{"key":"477_CR69","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.echo.2015.07.015","volume":"28","author":"M Ro\u015fca","year":"2015","unstructured":"Ro\u015fca, M. et al. Right ventricular remodeling, its correlates, and its clinical impact in hypertrophic cardiomyopathy. J. Am. Soc. Echocardiogr. 28, 1329\u20131338 (2015).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"477_CR70","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cardfail.2010.05.004","volume":"16","author":"EF Aziz","year":"2010","unstructured":"Aziz, E. F. et al. Right ventricular dysfunction is a strong predictor of developing atrial fibrillation in acutely decompensated heart failure patients, ACAP-HF data analysis. J. Card. Fail. 16, 827\u2013834 (2010).","journal-title":"J. Card. Fail."},{"key":"477_CR71","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2215\/CJN.08781010","volume":"6","author":"ME Grams","year":"2011","unstructured":"Grams, M. E. et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin. J. Am. Soc. Nephrol. 6, 966\u2013973 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"477_CR72","first-page":"296","volume":"65","author":"F Kanat","year":"2007","unstructured":"Kanat, F., Vatansev, H. & Teke, T. Diuretics, plasma brain natriuretic peptide and chronic obstructive pulmonary disease. Neth. J. Med. 65, 296\u2013300 (2007).","journal-title":"Neth. J. Med."},{"key":"477_CR73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCULATIONAHA.111.082511","volume":"127","author":"AM Khan","year":"2013","unstructured":"Khan, A. M. et al. Low serum magnesium and the development of atrial fibrillation in the community: the framingham heart study. Circulation 127, 33\u201338 (2013).","journal-title":"Circulation"},{"key":"477_CR74","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1016\/j.ijcard.2013.08.048","volume":"168","author":"BP Krijthe","year":"2013","unstructured":"Krijthe, B. P. et al. Serum potassium levels and the risk of atrial fibrillation: the rotterdam study. Int. J. Cardiol. 168, 5411\u20135415 (2013).","journal-title":"Int. J. Cardiol."},{"key":"477_CR75","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/ehjcvp\/pvz024","volume":"6","author":"L Hagengaard","year":"2020","unstructured":"Hagengaard, L. et al. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs. Eur. Heart J. Cardiovasc. Pharmacother. 6, 137\u2013144 (2020).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"477_CR76","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1378\/chest.11-1597","volume":"142","author":"M Wilchesky","year":"2012","unstructured":"Wilchesky, M., Ernst, P., Brophy, J. M., Platt, R. W. & Suissa, S. Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest 142, 305\u2013311 (2012).","journal-title":"Chest"},{"key":"477_CR77","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1378\/chest.114.2.411","volume":"114","author":"M Cazzola","year":"1998","unstructured":"Cazzola, M. et al. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia. Chest 114, 411\u2013415 (1998).","journal-title":"Chest"},{"key":"477_CR78","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","volume":"125","author":"SR Salpeter","year":"2004","unstructured":"Salpeter, S. R., Ormiston, T. M. & Salpeter, E. E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 125, 2309\u20132321 (2004).","journal-title":"Chest"},{"key":"477_CR79","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2174\/0929867311320120003","volume":"20","author":"L Fuso","year":"2013","unstructured":"Fuso, L., Mores, N., Valente, S., Malerba, M. & Montuschi, P. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Curr. Med. Chem. 20, 1477\u20131495 (2013).","journal-title":"Curr. Med. Chem."},{"key":"477_CR80","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1378\/chest.127.6.2057","volume":"127","author":"EM Kallergis","year":"2005","unstructured":"Kallergis, E. M. et al. Acute electrophysiologic effects of inhaled salbutamol in humans. Chest 127, 2057\u20132063 (2005).","journal-title":"Chest"},{"key":"477_CR81","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2174\/0929867311320120002","volume":"20","author":"P Montuschi","year":"2013","unstructured":"Montuschi, P., Macagno, F., Valente, S. & Fuso, L. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD. Curr. Med. Chem. 20, 1464\u20131476 (2013).","journal-title":"Curr. Med. Chem."},{"key":"477_CR82","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/thoraxjnl-2011-201275","volume":"68","author":"S Singh","year":"2013","unstructured":"Singh, S., Loke, Y. K., Enright, P. & Furberg, C. D. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax 68, 114\u2013116 (2013).","journal-title":"Thorax"},{"key":"477_CR83","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1164\/rccm.2110093","volume":"166","author":"NR Anthonisen","year":"2002","unstructured":"Anthonisen, N. R., Connett, J. E., Enright, P. L., Manfreda, J. & Lung Health Study Research G Hospitalizations and mortality in the lung health study. Am. J. Respir. Crit. Care Med. 166, 333\u2013339 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1378\/chest.08-2367","volume":"137","author":"SS Ogale","year":"2010","unstructured":"Ogale, S. S., Lee, T. A., Au, D. H., Boudreau, D. M. & Sullivan, S. D. Cardiovascular events associated with ipratropium bromide in COPD. Chest 137, 13\u201319 (2010).","journal-title":"Chest"},{"key":"477_CR85","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/ijcp.12596","volume":"69","author":"JM Hohlfeld","year":"2015","unstructured":"Hohlfeld, J. M. et al. Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials. Int. J. Clin. Pract. 69, 72\u201380 (2015).","journal-title":"Int. J. Clin. Pract."},{"key":"477_CR86","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1378\/chest.130.6.1695","volume":"130","author":"S Kesten","year":"2006","unstructured":"Kesten, S., Jara, M., Wentworth, C. & Lanes, S. Pooled clinical trial analysis of tiotropium safety. Chest 130, 1695\u20131703 (2006).","journal-title":"Chest"},{"key":"477_CR87","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","volume":"359","author":"DP Tashkin","year":"2008","unstructured":"Tashkin, D. P. et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 1543\u20131554 (2008).","journal-title":"N. Engl. J. Med."},{"key":"477_CR88","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.rmed.2014.07.011","volume":"108","author":"JA Wedzicha","year":"2014","unstructured":"Wedzicha, J. A. et al. Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients. Respir. Med. 108, 1498\u20131507 (2014).","journal-title":"Respir. Med."},{"key":"477_CR89","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/archinternmed.2009.297","volume":"169","author":"CF Christiansen","year":"2009","unstructured":"Christiansen, C. F. et al. Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study. Arch. Intern. Med. 169, 1677\u20131683 (2009).","journal-title":"Arch. Intern. Med."},{"key":"477_CR90","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archinte.166.9.1016","volume":"166","author":"CS van der Hooft","year":"2006","unstructured":"van der Hooft, C. S. et al. Corticosteroids and the risk of atrial fibrillation. Arch. Intern. Med. 166, 1016\u20131020 (2006).","journal-title":"Arch. Intern. Med."},{"key":"477_CR91","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/COPD.S433583","volume":"19","author":"EK Kim","year":"2024","unstructured":"Kim, E. K. et al. Cardiovascular events according to inhaler therapy and comorbidities in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct Pulmon Dis. 19, 243\u2013254 (2024).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"477_CR92","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.ede.0000158743.90664.a7","volume":"16","author":"C Huerta","year":"2005","unstructured":"Huerta, C., Lanes, S. F. & Garc\u00eda Rodr\u00edguez, L. A. Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 16, 360\u2013366 (2005).","journal-title":"Epidemiology"},{"key":"477_CR93","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1445-5994.2009.02109.x","volume":"40","author":"R Wood-Baker","year":"2010","unstructured":"Wood-Baker, R., Cochrane, B. & Naughton, M. T. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment. Intern. Med. J. 40, 94\u2013101 (2010).","journal-title":"Intern. Med. J."},{"key":"477_CR94","first-page":"322","volume":"135","author":"CE Eiriksson Jr.","year":"1987","unstructured":"Eiriksson, C. E. Jr., Writer, S. L. & Vestal, R. E. Theophylline-induced alterations in cardiac electrophysiology in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 135, 322\u2013326 (1987).","journal-title":"Am. Rev. Respir. Dis."},{"key":"477_CR95","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1517\/14656560903200667","volume":"10","author":"D Shukla","year":"2009","unstructured":"Shukla, D., Chakraborty, S., Singh, S. & Mishra, B. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease. Expert. Opin. Pharmacother. 10, 2343\u20132356 (2009).","journal-title":"Expert. Opin. Pharmacother."},{"key":"477_CR96","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S2213-2600(18)30331-X","volume":"6","author":"KF Rabe","year":"2018","unstructured":"Rabe, K. F. et al. Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial. Lancet Respir. Med. 6, 827\u2013836 (2018).","journal-title":"Lancet Respir. Med."},{"key":"477_CR97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1753465812466167","volume":"7","author":"Y Oba","year":"2013","unstructured":"Oba, Y. & Lone, N. A. Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ther. Adv. Respir. Dis. 7, 13\u201324 (2013).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"477_CR98","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1164\/rccm.201402-0385CI","volume":"189","author":"RK Albert","year":"2014","unstructured":"Albert, R. K. & Schuller, J. L. Network CCR. Macrolide antibiotics and the risk of cardiac arrhythmias. Am. J. Respir. Crit. Care Med. 189, 1173\u20131180 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR99","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2147\/JMDH.S445549","volume":"17","author":"A Ceasovschih","year":"2024","unstructured":"Ceasovschih, A. et al. Electrocardiogram features in non-cardiac diseases: from mechanisms to practical aspects. J. Multidiscip. Healthc. 17, 1695\u20131719 (2024).","journal-title":"J. Multidiscip. Healthc."},{"key":"477_CR100","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s11739-024-03653-0","volume":"19","author":"T Bucci","year":"2024","unstructured":"Bucci, T. et al. Low-dose azithromycin prophylaxis in patients with atrial fibrillation and chronic obstructive pulmonary disease. Intern. Emerg. Med. 19, 1615\u20131623 (2024).","journal-title":"Intern. Emerg. Med."},{"key":"477_CR101","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1183\/09031936.03.00051502","volume":"21","author":"P Buch","year":"2003","unstructured":"Buch, P., Friberg, J., Scharling, H., Lange, P. & Prescott, E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur. Respir. J. 21, 1012\u20131016 (2003).","journal-title":"Eur. Respir. J."},{"key":"477_CR102","first-page":"297","volume":"59","author":"M Grabicki","year":"2008","unstructured":"Grabicki, M., Parysek, H., Batura-Gabryel, H. & Brodnicka, I. Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease. J. Physiol. Pharmacol. 59, 297\u2013301 (2008).","journal-title":"J. Physiol. Pharmacol."},{"key":"477_CR103","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/eurjpc\/zwaf119","volume":"32","author":"CP Gale","year":"2025","unstructured":"Gale, C. P. et al. Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study. Eur. J. Prev. Cardiol. 32, 1445\u20131460 (2025).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"477_CR104","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejim.2024.07.039","volume":"130","author":"U Qamar","year":"2024","unstructured":"Qamar, U., Qamar, W. & Agarwal, S. Atrial fibrillation-related mortality trends among adults with comorbid chronic obstructive pulmonary disease in the United States from 1999\u20132020. Eur. J. Intern. Med. 130, 165\u2013167 (2024).","journal-title":"Eur. J. Intern. Med."},{"key":"477_CR105","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.3390\/jcm13175173","volume":"13","author":"A S\u00e1-Sousa","year":"2024","unstructured":"S\u00e1-Sousa, A. et al. Cardiovascular risk in patients with chronic obstructive pulmonary disease: a systematic review. J. Clin. Med. 13, 5173 (2024).","journal-title":"J. Clin. Med."},{"key":"477_CR106","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/thoraxjnl-2012-202103","volume":"67","author":"J Steer","year":"2012","unstructured":"Steer, J., Gibson, J. & Bourke, S. C. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 67, 970\u2013976 (2012).","journal-title":"Thorax"},{"key":"477_CR107","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/life15040533","volume":"15","author":"M Ari","year":"2025","unstructured":"Ari, M. & Ari, E. Efficacy of age-adjusted dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score in predicting long-term survival in COPD-Related persistent hypercapnic respiratory failure. Life 15, 533 (2025).","journal-title":"Life"},{"key":"477_CR108","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1164\/ajrccm.164.4.2007085","volume":"164","author":"S Heindl","year":"2001","unstructured":"Heindl, S., Lehnert, M., Cri\u00e9e, C. P., Hasenfuss, G. & Andreas, S. Marked sympathetic activation in patients with chronic respiratory failure. Am. J. Respir. Crit. Care Med. 164, 597\u2013601 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR109","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1378\/chest.106.5.1432","volume":"106","author":"M Volterrani","year":"1994","unstructured":"Volterrani, M. et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 106, 1432\u20131437 (1994).","journal-title":"Chest"},{"key":"477_CR110","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijcard.2018.11.091","volume":"287","author":"D Linz","year":"2019","unstructured":"Linz, D. et al. Role of autonomic nervous system in atrial fibrillation. Int. J. Cardiol. 287, 181\u2013188 (2019).","journal-title":"Int. J. Cardiol."},{"key":"477_CR111","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1183\/09031936.00175714","volume":"45","author":"D Linz","year":"2015","unstructured":"Linz, D. et al. Obstructive respiratory events and premature atrial contractions after cardioversion. Eur. Respir. J. 45, 1332\u20131340 (2015).","journal-title":"Eur. Respir. J."},{"key":"477_CR112","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.hrthm.2011.03.053","volume":"8","author":"D Linz","year":"2011","unstructured":"Linz, D., Schotten, U., Neuberger, H. R., B\u00f6hm, M. & Wirth, K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 8, 1436\u20131443 (2011).","journal-title":"Heart Rhythm."},{"key":"477_CR113","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3390\/jcm13102803","volume":"13","author":"J de-Miguel-Diez","year":"2024","unstructured":"de-Miguel-Diez, J. et al. Detrimental impact of atrial fibrillation among patients hospitalized for acute exacerbation of COPD: results of a population-based study in spain from 2016\u20132021. J. Clin. Med. 13, 2803 (2024).","journal-title":"J. Clin. Med."},{"key":"477_CR114","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12890-024-03035-4","volume":"24","author":"EL Graul","year":"2024","unstructured":"Graul, E. L. et al. Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study. BMC Pulm. Med. 24, 221 (2024).","journal-title":"BMC Pulm. Med."},{"key":"477_CR115","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","volume":"55","author":"CB de Vos","year":"2010","unstructured":"de Vos, C. B. et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J. Am. Coll. Cardiol. 55, 725\u2013731 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"477_CR116","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00059-015-4305-4","volume":"40","author":"TS Tischer","year":"2015","unstructured":"Tischer, T. S. et al. Prevalence of atrial fibrillation and the HATCH score: Intensified monitoring of patients with high HATCH score. Herz 40, 803\u2013808 (2015).","journal-title":"Herz"},{"key":"477_CR117","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/europace\/eur406","volume":"14","author":"R Pisters","year":"2012","unstructured":"Pisters, R. et al. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the euro heart survey. Europace 14, 666\u2013674 (2012).","journal-title":"Europace"},{"key":"477_CR118","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.04.034","volume":"24","author":"R Nadeem","year":"2015","unstructured":"Nadeem, R. et al. Potential augmentation of the risk of ischemic cerebrovascular accident by chronic obstructive pulmonary disease in patients with atrial fibrillation. J. Stroke Cerebrovasc. Dis. 24, 1893\u20131896 (2015).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"477_CR119","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/life15020154","volume":"15","author":"HL Tsai","year":"2025","unstructured":"Tsai, H. L. et al. The risk of ischemic stroke in patients with chronic obstructive pulmonary disease and atrial fibrillation. Life 15, 154 (2025).","journal-title":"Life"},{"key":"477_CR120","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.annemergmed.2015.07.017","volume":"66","author":"CL Atzema","year":"2015","unstructured":"Atzema, C. L. et al. A clinical decision instrument for 30-Day death after an emergency department visit for atrial fibrillation: the atrial fibrillation in the emergency room (AFTER) study. Ann. Emerg. Med. 66, 658\u201368 e6 (2015).","journal-title":"Ann. Emerg. Med."},{"key":"477_CR121","doi-asserted-by":"publisher","first-page":"309","DOI":"10.14740\/jocmr6243","volume":"17","author":"S Eltawansy","year":"2025","unstructured":"Eltawansy, S. et al. Impact of chronic obstructive pulmonary disease burden on patients with atrial fibrillation: a nationwide study. J. Clin. Med. Res. 17, 309\u2013319 (2025).","journal-title":"J. Clin. Med. Res."},{"key":"477_CR122","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032785","volume":"13","author":"T Bucci","year":"2024","unstructured":"Bucci, T. et al. Risk of death and cardiovascular events in asian patients with atrial fibrillation and chronic obstructive pulmonary disease: a report from the prospective APHRS registry. J. Am. Heart Assoc. 13, e032785 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"477_CR123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/01.CIR.86.1.12","volume":"86","author":"IS Anand","year":"1992","unstructured":"Anand, I. S. et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 86, 12\u201321 (1992).","journal-title":"Circulation"},{"key":"477_CR124","doi-asserted-by":"publisher","first-page":"998","DOI":"10.4187\/respcare.10876","volume":"68","author":"MW Hess","year":"2023","unstructured":"Hess, M. W. Oxygen Therapy in COPD. Respir. Care 68, 998\u20131012 (2023).","journal-title":"Respir. Care"},{"key":"477_CR125","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1164\/rccm.200507-1161WS","volume":"174","author":"TL Croxton","year":"2006","unstructured":"Croxton, T. L. & Bailey, W. C. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am. J. Respir. Crit. Care Med. 174, 373\u2013378 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR126","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.006322","volume":"11","author":"A Hirayama","year":"2018","unstructured":"Hirayama, A. et al. Acute exacerbation of chronic obstructive pulmonary disease and subsequent risk of emergency department visits and hospitalizations for atrial fibrillation. Circ. Arrhythm. Electrophysiol. 11, e006322 (2018).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"477_CR127","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jacep.2022.12.002","volume":"9","author":"AD Elliott","year":"2023","unstructured":"Elliott, A. D. et al. An exercise and physical activity program in patients with atrial fibrillation: The ACTIVE-AF Randomized Controlled Trial. JACC Clin. Electrophysiol. 9, 455\u2013465 (2023).","journal-title":"JACC Clin. Electrophysiol."},{"key":"477_CR128","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCEP.113.001244","volume":"7","author":"RR Huxley","year":"2014","unstructured":"Huxley, R. R. et al. Physical activity, obesity, weight change, and risk of atrial fibrillation: the atherosclerosis risk in communities study. Circ. Arrhythm. Electrophysiol. 7, 620\u2013625 (2014).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"477_CR129","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1164\/ajrccm.160.6.9902115","volume":"160","author":"C Landbo","year":"1999","unstructured":"Landbo, C., Prescott, E., Lange, P., Vestbo, J. & Almdal, T. P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160, 1856\u20131861 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR130","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40519-017-0456-z","volume":"23","author":"F Spelta","year":"2018","unstructured":"Spelta, F., Fratta Pasini, A. M., Cazzoletti, L. & Ferrari, M. Body weight and mortality in COPD: focus on the obesity paradox. Eat. Weight. Disord. 23, 15\u201322 (2018).","journal-title":"Eat. Weight. Disord."},{"key":"477_CR131","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo, J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 187, 347\u2013365 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR132","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00392-023-02217-0","volume":"113","author":"A Agusti","year":"2024","unstructured":"Agusti, A. et al. GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists. Clin. Res. Cardiol. 113, 195\u2013204 (2024).","journal-title":"Clin. Res. Cardiol."},{"key":"477_CR133","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","volume":"188","author":"PJ Barnes","year":"2013","unstructured":"Barnes, P. J. Theophylline. Am. J. Respir. Crit. Care Med. 188, 901\u2013906 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"477_CR134","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","volume":"374","author":"PM Calverley","year":"2009","unstructured":"Calverley, P. M. et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 374, 685\u2013694 (2009).","journal-title":"Lancet"},{"key":"477_CR135","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-2600(15)00518-4","volume":"4","author":"L Lahousse","year":"2016","unstructured":"Lahousse, L., Verhamme, K. M., Stricker, B. H. & Brusselle, G. G. Cardiac effects of current treatments of chronic obstructive pulmonary disease. Lancet Respir. Med. 4, 149\u2013164 (2016).","journal-title":"Lancet Respir. Med."},{"key":"477_CR136","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.hrthm.2018.06.044","volume":"15","author":"SC You","year":"2018","unstructured":"You, S. C. et al. Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease. Heart Rhythm. 15, 1825\u20131832 (2018).","journal-title":"Heart Rhythm."},{"key":"477_CR137","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder, I. C. et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for cardio-thoracic surgery (EACTS). Eur. Heart J. 45, 3314\u20133414 (2024).","journal-title":"Eur. Heart J."},{"key":"477_CR138","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijcard.2015.09.062","volume":"202","author":"MT Durheim","year":"2016","unstructured":"Durheim, M. T. et al. Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial. Int. J. Cardiol. 202, 589\u2013594 (2016).","journal-title":"Int. J. Cardiol."},{"key":"477_CR139","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1093\/eurheartj\/ehab453","volume":"42","author":"GF Romiti","year":"2021","unstructured":"Romiti, G. F. et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. Eur. Heart J. 42, 3541\u20133554 (2021).","journal-title":"Eur. Heart J."},{"key":"477_CR140","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/COPD.S174443","volume":"14","author":"M Rodr\u00edguez-Ma\u00f1ero","year":"2019","unstructured":"Rodr\u00edguez-Ma\u00f1ero, M. et al. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population. Int. J. Chron. Obstruct Pulmon Dis. 14, 371\u2013380 (2019).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"477_CR141","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jchf.2019.05.009","volume":"7","author":"M Canepa","year":"2019","unstructured":"Canepa, M. et al. Diagnostic and therapeutic gaps in patients with heart failure and chronic obstructive pulmonary disease. JACC Heart Fail. 7, 823\u2013833 (2019).","journal-title":"JACC Heart Fail."},{"key":"477_CR142","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1513\/AnnalsATS.201708-626OC","volume":"15","author":"MT Dransfield","year":"2018","unstructured":"Dransfield, M. T. et al. \u03b2-Blocker therapy and clinical outcomes in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk. an observational substudy of SUMMIT. Ann. Am. Thorac. Soc. 15, 608\u2013614 (2018).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"477_CR143","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1056\/NEJMoa1908142","volume":"381","author":"MT Dransfield","year":"2019","unstructured":"Dransfield, M. T. et al. Metoprolol for the prevention of acute exacerbations of COPD. N. Engl. J. Med. 381, 2304\u20132314 (2019).","journal-title":"N. Engl. J. Med."},{"key":"477_CR144","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.chest.2024.07.163","volume":"167","author":"BJ Lipworth","year":"2025","unstructured":"Lipworth, B. J. & Devereux, G. Use of \u03b2-Blockers in COPD: the long and winding road. Chest 167, 37\u201339 (2025).","journal-title":"Chest"},{"key":"477_CR145","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jama.2024.8771","volume":"332","author":"G Devereux","year":"2024","unstructured":"Devereux, G. et al. Bisoprolol in patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS randomized clinical trial. Jama 332, 462\u2013470 (2024).","journal-title":"Jama"},{"key":"477_CR146","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2147\/COPD.S511117","volume":"20","author":"H Liang","year":"2025","unstructured":"Liang, H. et al. The impact of beta-blockers and renin-angiotensin-aldosterone system inhibitors on the prognosis of atrial fibrillation patients with chronic obstructive pulmonary disease: a nation-wide registry study. Int. J. Chron. Obstruct Pulmon Dis. 20, 699\u2013708 (2025).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"477_CR147","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0002-9149(75)90051-X","volume":"35","author":"S Goldman","year":"1975","unstructured":"Goldman, S., Probst, P., Selzer, A. & Cohn, K. Inefficacy of \u201ctherapeutic\u201d serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. Am. J. Cardiol. 35, 651\u2013655 (1975).","journal-title":"Am. J. Cardiol."},{"key":"477_CR148","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.007775","volume":"13","author":"BA Steinberg","year":"2020","unstructured":"Steinberg, B. A. et al. Factors associated with large improvements in health-related quality of life in patients with atrial fibrillation: results from ORBIT-AF. Circ. Arrhythm. Electrophysiol. 13, e007775 (2020).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"477_CR149","first-page":"43","volume":"16","author":"N Wolkove","year":"2009","unstructured":"Wolkove, N. & Baltzan, M. Amiodarone pulmonary toxicity. Can. Respir. J. 16, 43\u201348 (2009).","journal-title":"Can. Respir. J."},{"key":"477_CR150","first-page":"1435","volume":"16","author":"R Sunderji","year":"2000","unstructured":"Sunderji, R., Kanji, Z. & Gin, K. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance. Can. J. Cardiol. 16, 1435\u20131440 (2000).","journal-title":"Can. J. Cardiol."},{"key":"477_CR151","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0735-1097(97)00157-5","volume":"30","author":"SN Singh","year":"1997","unstructured":"Singh, S. N. et al. Pulmonary effect of amiodarone in patients with heart failure fn1fn1this study was supported by the department of veterans affairs cooperative studies program of the medical research service (Washington, D.C.), Sanofi Winthrop Recherche (Paris, France) and Wyeth-Ayerst Laboratories (Philadelphia, Pennsylvania). J. Am. Coll. Cardiology 30, 514\u2013517 (1997).","journal-title":"J. Am. Coll. Cardiology"},{"key":"477_CR152","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4137\/CCRep.S39809","volume":"9","author":"AJ Sweidan","year":"2016","unstructured":"Sweidan, A. J., Singh, N. K., Dang, N., Lam, V. & Datta, J. Amiodarone-Induced pulmonary toxicity - a frequently missed complication. Clin. Med. Insights Case Rep. 9, 91\u201394 (2016).","journal-title":"Clin. Med. Insights Case Rep."},{"key":"477_CR153","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/pds.5233","volume":"30","author":"A Tave","year":"2021","unstructured":"Tave, A. et al. Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics. Pharmacoepidemiol. Drug. Saf. 30, 1353\u20131359 (2021).","journal-title":"Pharmacoepidemiol. Drug. Saf."},{"key":"477_CR154","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.2147\/COPD.S145913","volume":"12","author":"YL Huang","year":"2017","unstructured":"Huang, Y. L. et al. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD. Int. J. Chron. Obstruct Pulmon Dis. 12, 2987\u20132996 (2017).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"477_CR155","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2147\/COPD.S242009","volume":"15","author":"J Recio Iglesias","year":"2020","unstructured":"Recio Iglesias, J. et al. Management of the COPD patient with comorbidities: an experts recommendation document. Int. J. Chron. Obstruct Pulmon Dis. 15, 1015\u20131037 (2020).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"477_CR156","doi-asserted-by":"publisher","first-page":"bcr2017219270","DOI":"10.1136\/bcr-2017-219270","volume":"2017","author":"AA Alsaad","year":"2017","unstructured":"Alsaad, A. A., Ortiz Gonzalez, Y., Austin, C. O. & Kusumoto, F. Revisiting propafenone toxicity. BMJ Case Rep. 2017, bcr2017219270 (2017).","journal-title":"BMJ Case Rep."},{"key":"477_CR157","doi-asserted-by":"publisher","unstructured":"Torres D., Parrinello G., Paterna S., Bellanca M., Licata G. Severe brochostenosis by oral propafenone immediately after commencing treatment. Am J Ther. https:\/\/doi.org\/10.1097\/MJT.0b013e3181fc2fab 2011.","DOI":"10.1097\/MJT.0b013e3181fc2fab"},{"key":"477_CR158","first-page":"69","volume":"2","author":"C Pepe","year":"2010","unstructured":"Pepe, C. et al. Cost-effectiveness analysis of propafenone and amiodarone for atrial fibrillation initial treatment. J. Brasileiro de. Economia da Sa\u00fade 2, 69\u201376 (2010).","journal-title":"J. Brasileiro de. Economia da Sa\u00fade"},{"key":"477_CR159","doi-asserted-by":"publisher","first-page":"e009294","DOI":"10.1161\/JAHA.118.009294","volume":"7","author":"S Arora","year":"2018","unstructured":"Arora, S. et al. Causes and predictors of readmission in patients with atrial fibrillation undergoing catheter ablation: a national population-based cohort study. J. Am. Heart Assoc. 7, e009294 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"477_CR160","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1161\/CIRCEP.110.960435","volume":"4","author":"SY Roh","year":"2011","unstructured":"Roh, S. Y. et al. Catheter ablation of atrial fibrillation in patients with chronic lung disease. Circ. Arrhythm. Electrophysiol. 4, 815\u2013822 (2011).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"477_CR161","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.19102\/icrm.2022.130806","volume":"13","author":"AM Maraey","year":"2022","unstructured":"Maraey, A. M. et al. Impact of chronic obstructive pulmonary disease on atrial fibrillation ablation outcomes according to the national readmission database. J. Innov. Card. Rhythm. Manag. 13, 5112\u20135119 (2022).","journal-title":"J. Innov. Card. Rhythm. Manag."},{"key":"477_CR162","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1055\/s-0035-1556063","volume":"36","author":"N Putcha","year":"2015","unstructured":"Putcha, N., Drummond, M. B., Wise, R. A. & Hansel, N. N. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin. Respir. Crit. Care Med. 36, 575\u2013591 (2015).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"477_CR163","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0300-2896(09)72857-1","volume":"45","author":"JB Soriano Ortiz","year":"2009","unstructured":"Soriano Ortiz, J. B., Almagro, P. & Sauleda Roig, J. [Causes of mortality in COPD]. Arch. Bronconeumol. 45, 8\u201313 (2009).","journal-title":"Arch. Bronconeumol."},{"key":"477_CR164","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejim.2017.08.016","volume":"47","author":"M Contoli","year":"2018","unstructured":"Contoli, M. et al. Inhaled corticosteroid\/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients. Eur. J. Intern. Med. 47, 82\u201386 (2018).","journal-title":"Eur. J. Intern. Med."},{"key":"477_CR165","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1465-9921-10-45","volume":"10","author":"EM Mortensen","year":"2009","unstructured":"Mortensen, E. M. et al. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir. Res. 10, 45 (2009).","journal-title":"Respir. Res."},{"key":"477_CR166","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.trsl.2013.05.001","volume":"162","author":"SP Bhatt","year":"2013","unstructured":"Bhatt, S. P. & Dransfield, M. T. Chronic obstructive pulmonary disease and cardiovascular disease. Transl. Res. 162, 237\u2013251 (2013).","journal-title":"Transl. Res."},{"key":"477_CR167","first-page":"416","volume":"5","author":"T Suzuki","year":"2016","unstructured":"Suzuki, T. et al. Editor\u2019s Choice-Biomarkers of acute cardiovascular and pulmonary diseases. Eur. Heart J. Acute Cardiovasc. Care 5, 416\u2013433 (2016).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"477_CR168","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1164\/rccm.202407-1320ST","volume":"210","author":"LC Myers","year":"2024","unstructured":"Myers, L. C. et al. A research agenda to improve outcomes in patients with chronic obstructive pulmonary disease and cardiovascular disease: an official american thoracic society research statement. Am. J. Respir. Crit. Care Med. 210, 715\u2013729 (2024).","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00477-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:05:47Z","timestamp":1770642347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00477-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":168,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1038\/s41533-025-00477-z","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}